https://www.prnewswire.com/news-releases/anixa-biosciences-announces-commencement-of-phase-1b-trial-of-its-breast-cancer-vaccine-at-cleveland-clinic-301659590.html
0
0
Anixa Biosciences Announces Commencement of Phase 1b Trial of its Breast Cancer Vaccine at Cleveland Clinic - PR Newswire
10/26/22 at 12:30pm
Organization
PRNewswire
Authors
Details
38 words
Summarize
Health Pharmaceuticals & Biotech Anixa Biosciences Announces Commencement Phase 1b Trial Breast Cancer Vaccine Nasdaq PRNewswire Cleveland Clinic Anixa Biosciences, Inc. ANIX
/PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases,...
Create an account or login to join the discussion